Vor Biopharma Inc. (VOR) Misses Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts VOR Hot Sheet
Join SI Premium – FREE
Vor Biopharma Inc. (NASDAQ: VOR) reported Q1 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Qualcomm stock climbs after SpaceX 5G network deal
- Citadel sees year-end stock rally as Wall Street’s biggest buyers return
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
